Drugs@FDA: FDA-Approved Drugs

Home | Previous Page

Abbreviated New Drug Application (ANDA): 212127
Company: MEITHEAL

Products on ANDA 212127

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	TE Code	RLD	RS
BUSULFAN	BUSULFAN	6MG/ML	INJECTABLE;INJECTION	Prescription	AP	No	No

Approval Date(s) and History, Letters, Labels, Reviews for ANDA 212127

Original Approvals or Tentative Approvals

Action Date	Submission	Action Type	Submission Classification	Review Priority; Orphan Status	Letters, Reviews, Labels, Patient Package Insert	Notes	Url
10/23/2020	ORIG-1	Approval		STANDARD		Label is not available on this site.

Therapeutic Equivalents for ANDA 212127

BUSULFAN

INJECTABLE;INJECTION; 6MG/ML
TE Code = AP

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	RLD	TE Code	Application No.	Company
BUSULFAN	BUSULFAN	6MG/ML	INJECTABLE;INJECTION	Prescription	No	AP	210148	ACCORD HLTHCARE INC
BUSULFAN	BUSULFAN	6MG/ML	INJECTABLE;INJECTION	Prescription	No	AP	209580	AMNEAL
BUSULFAN	BUSULFAN	6MG/ML	INJECTABLE;INJECTION	Prescription	No	AP	205672	HOSPIRA
BUSULFAN	BUSULFAN	6MG/ML	INJECTABLE;INJECTION	Prescription	No	AP	212127	MEITHEAL
BUSULFAN	BUSULFAN	6MG/ML	INJECTABLE;INJECTION	Prescription	No	AP	207050	PHARMASCIENCE INC
BUSULFAN	BUSULFAN	6MG/ML	INJECTABLE;INJECTION	Prescription	No	AP	215235	PRINSTON INC
BUSULFAN	BUSULFAN	6MG/ML	INJECTABLE;INJECTION	Prescription	No	AP	210931	SHILPA
BUSULFEX	BUSULFAN	6MG/ML	INJECTABLE;INJECTION	Prescription	Yes	AP	020954	OTSUKA PHARM